US Edition
PL BioScience appoints Oliver Dick as chief technology officer - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
PL BioScience appoints Oliver Dick as chief technology officer - Pharmafile
PL BioScience, a German life sciences company specialising in the production and development of human platelet lysate (HPL) for cell expansion, has announced the strengthening of its management team with the appointment of Oliver Dick as chief technology officer. This intends to support HPL upscaling in alignment with growing global demand for its animal-free cell […] The post PL BioScience appoints Oliver Dick as chief technology officer appear…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
